ライフサイエンスコーパス: recurrent infection

1 read distribution provide protection against recurrent infection.

2 ce VZV replication in skin during primary or recurrent infection.

3 ith Cryptosporidium infections, particularly recurrent infection.

4 verely defective in chemotaxis, resulting in recurrent infection.

5 a from this reservoir might be the source of recurrent infection.

6 airways, impairing respiration and promoting recurrent infection.

7 substantial risk for operative mortality or recurrent infection.

8 cell memory that confers protection against recurrent infection.

9 sia species appeared to result in chronic or recurrent infection.

10 that does not prevent invasive amebiasis or recurrent infection.

11 s who were seropositive before BMT underwent recurrent infection.

12 ls, but are frequent pathogens and can cause recurrent infection.

13 pressure and prevent or treat persistent and recurrent infection.

14 protective or nonprotective immunity against recurrent infection.

15 ently, which represents a lifelong source of recurrent infection.

16 ful patient outcomes including prevention of recurrent infection.

17 iated with an elevated risk of persistent or recurrent infection.

18 re less effective for treating refractory or recurrent infection.

19 led treatment at 17 weeks or later or from a recurrent infection.

20 load before transplantation will have rapid, recurrent infection.

21 therapy and a major cause of persistent and recurrent infections.

22 amages the airways and fails to protect from recurrent infections.

23 f the 12 mothers and 9 of the 21 infants had recurrent infections.

24 hould be performed, especially in those with recurrent infections.

25 en implicated in biofilms and in chronic and recurrent infections.

26 mes when antibody is present, such as during recurrent infections.

27 cy disorder characterized by neutropenia and recurrent infections.

28 proportion of patients suffer from multiple recurrent infections.

29 es, were found in a lymphopenic patient with recurrent infections.

30 cteria also serve as reservoirs important in recurrent infections.

31 least once, and 25% of these women will have recurrent infections.

32 nd mortality by plugging airways and causing recurrent infections.

33 women, and may be associated with chronic or recurrent infections.

34 rrow, ineffective neutrophil production, and recurrent infections.

35 rns of the organisms causing the initial and recurrent infections.

36 vers of cirrhosis patients with a history of recurrent infections.

37 m IgM to IgG and IgA, a defect that leads to recurrent infections.

38 ave significant morbidity and mortality from recurrent infections.

39 osed by environmental stresses, particularly recurrent infections.

40 ion of microbicidal oxidants leads to severe recurrent infections.

41 s indicate that ethanol addicts are prone to recurrent infections.

42 ssociated with thrombocytopenia, eczema, and recurrent infections.

43 ival of viruses that establish persistent or recurrent infections.

44 (9)/L, two had agranulocytosis, and four had recurrent infections.

45 clonal population and substrain shuffling in recurrent infections.

46 e to produce superoxide (O2-.), resulting in recurrent infections.

47 n part by pulmonary abnormalities, including recurrent infections.

48 on, are commonly associated with chronic and recurrent infections.

49 s, inadequate postnatal nutrient intake, and recurrent infections.

50 erized by impaired leukocyte recruitment and recurrent infections.

51 es the need for vaccines to prevent UTIs and recurrent infections.

52 in human disease, particularly in regards to recurrent infections.

53 ng the capacity to establish lifelong latent-recurrent infections.

54 mental contaminants, increasing the risk for recurrent infections.

55 plicated in resistance to antimicrobials and recurrent infections.

56 If untreated, patients succumb to recurrent infections.

57 ng patients had no evidence of persistent or recurrent infections.

58 may prevent the establishment of latency and recurrent infections.

59 ies diagnosed with hypogammaglobulinemia and recurrent infections.

60 tions in order to deal more efficiently with recurrent infections.

61 GR with primary infection and 3 asymptomatic recurrent infections.

62 ency, poor humoral response to antigens, and recurrent infections.

63 RA) and manifests chiefly as neutropenia and recurrent infections.

64 accines focused on preventing both acute and recurrent infections.

65 erized by impaired leukocyte recruitment and recurrent infections.

66 which reside in the urothelium and can seed recurrent infections.

67 only a minority of people experience severe recurrent infections.

68 f virus in HCMV-experienced hosts undergoing recurrent infection (0.61 units/day; 95% CI, 0.55-0.7 un

69 s (4), gastrointestinal intolerance (4), and recurrent infections (3).

70 These bacteria may serve as a reservoir for recurrent infections, a common problem affecting million

71 ate, leading to severe immunodeficiency with recurrent infections (ADA-SCID).

72 ections at baseline were at highest risk for recurrent infection (adjusted odds ratio, 2.5 and 2.4, r

73 Recurrent infection after a negative posttreatment UBT a

74 ociated with a reduced risk of persistent or recurrent infection after adjustment for other predictor

75 ferral of partners in reducing persistent or recurrent infection among patients with gonorrhea (3 per

76 Thus far, interventions designed to reduce recurrent infections among household members have had li

77 infection can impact the risk for developing recurrent infection and has implications for the develop

78 apoptosis (TWEAK; TNFSF12) in a kindred with recurrent infection and impaired antibody responses to p

79 rus-specific CD8 T cells home to the site of recurrent infection and participate in viral clearance.

80 lux, but little is known about its impact on recurrent infection and renal scarring.

81 hepatitis B virus infection were hampered by recurrent infection and subsequent allograft failure.

82 he male sexual partner of the patient with a recurrent infection and the patient, an isolate from the

83 m Rac2 knockout mice and from a patient with recurrent infections and a dominant-negative mutation in

84 ed primary immunodeficiency characterized by recurrent infections and a marked predisposition to deve

85 nt assimilation but is also characterized by recurrent infections and chronic inflammation, implying

86 Staphylococcus aureus) biofilm, a source of recurrent infections and chronic inflammation.

87 In this report we describe a child with recurrent infections and clinical evidence of impaired p

88 A patient is described who has recurrent infections and defective neutrophil cellular f

89 CGD patients suffer from recurrent infections and exuberant and persistent tissue

90 ct in chronic granulomatous disease, causing recurrent infections and granulomatous complications.

91 on the efficacy of decolonization to prevent recurrent infections and highlights the adaptive potenti

92 usceptibility of DOCK8-deficient patients to recurrent infections and malignant disease.

93 phylaxis may not be effective for preventing recurrent infections and may result in antimicrobial res

94 transcription 3 (STAT3) mutations, including recurrent infections and mucocutaneous candidiasis, whic

95 rome characterized by hypogammaglobulinemia, recurrent infections and multiple autoimmune clinical fe

96 gene expressed by CD4(+) T cells suffer from recurrent infections and often develop autoimmune disord

97 gap hinders the ability to clinically manage recurrent infections and reconstruct transmission networ

98 mining those patients who are susceptible to recurrent infections and renal scarring following urinar

99 iveness of interventions designed to prevent recurrent infections and renal scarring.

100 Secondary aims were analyses of the rate of recurrent infections and reoperations, and time trends i

101 from a consanguineous family suffering from recurrent infections and severe lupuslike autoimmunity.

102 In 3 families, we identified 4 children with recurrent infections and varying clinical manifestations

103 virologic response at 12 weeks, 10 (23%) had recurrent infection, and 3 (7%) died (2 from nonfunction

104 isk of HPV16 infection, high viral load, and recurrent infection, and was also more strongly associat

105 on, and less frequently, bowel inflammation, recurrent infections, and angiopathic thromboembolic dis

106 ned immunodeficiency characterized by atopy, recurrent infections, and cancer susceptibility.

107 involving increased innate immune response, recurrent infections, and complex somatic features.

108 ncludes hyaline deposits in multiple organs, recurrent infections, and death within the first 2 years

109 clude temperature and electrolyte imbalance, recurrent infections, and failure to thrive.

110 rombocytopenia, small platelet size, eczema, recurrent infections, and increased risk of autoimmune d

111 racterized by microthrombocytopenia, eczema, recurrent infections, and susceptibility to autoimmunity

112 nd syndromes most frequently associated with recurrent infection are presented, along with discrimina

113 It has been proposed that recurrent infections are a result of the reintroduction

114 proaches targeting high-risk populations for recurrent infections are needed.

115 s a T-cell defect frequently presenting with recurrent infections, as well as associated immune dysre

116 There was no history of infectious exposure, recurrent infection, aspiration, or choking.

117 ent duration and assessment of persistent or recurrent infection at the completion of therapy.

118 f childhood-onset hypogammaglobulinemia with recurrent infections, autoimmune features, and adrenal i

119 hat autosomal recessive TPP2 mutations cause recurrent infections, autoimmunity, and neurodevelopment

120 tential of person-to-person transmission and recurrent infections but perhaps not for other genotypin

121 monocytes are most commonly associated with recurrent infection, but abnormalities of immunoglobulin

122 Although recurrent infections can be observed in patients with de

123 AT patients suffer from recurrent infections caused by both cellular and humoral

124 chanism underlying the susceptibility to the recurrent infections commonly seen in HIES.

125 lower risk of mortality and similar odds of recurrent infections compared with nafcillin or oxacilli

126 We identified three unrelated children with recurrent infections, congenital leukopenia including ne

127 ial factors that contribute to the course of recurrent infection could inform strategies to reduce re

128 Primary and recurrent infections cycle virus particles between neuro

129 disorder of persistent lung inflammation and recurrent infection, defined by a common pathological en

130 pha (IkappaBalpha) are susceptible to severe recurrent infections, despite normal T and B cell number

131 However, in patients with recurrent infections, different substrains of the establ

132 in (Ig)M syndrome (X-HIGM), characterized by recurrent infections due to impaired immunoglobulin clas

133 lish SOCE cause severe immunodeficiency with recurrent infections due to impaired T cell function.

134 Staphylococcus aureus causes persistent, recurrent infections (e.g., osteomyelitis) by forming bi

135 (encoding GP130 p.N404Y) who presented with recurrent infections, eczema, bronchiectasis, high IgE,

136 of Wiskott-Aldrich syndrome (WAS), including recurrent infections, eczema, thrombocytopenia, defectiv

137 ry immunodeficiency that is characterized by recurrent infections, hematopoietic malignancies, eczema

138 All patients presented with recurrent infections, hepatosplenomegaly, anaemia, and e

139 ses of hypogammaglobulinemia predisposing to recurrent infections, higher incidence of autoimmunity,

140 s are increasingly utilized for treatment of recurrent infections (i.e., Clostridium difficile) in th

141 be central to the altered responsiveness to recurrent infection in these patients.

142 Among recurrent infections in 41 individuals, there were 42 re

143 fit in preclinical animal models and prevent recurrent infections in human clinical trials.

144 D46-Jagged1 crosstalk is responsible for the recurrent infections in subpopulations of these patients

145 al wisdom dictates that uropathogens causing recurrent infections in such individuals come from the f

146 ation.IMPORTANCE HSV-2 causes very localized recurrent infections in the skin and genital mucosa.

147 provide a potential mechanism underlying the recurrent infections in WAS patients.

148 mechanism underlying phagocytic defects and recurrent infections in WAS patients.

149 l mouse model of protective immunity against recurrent infection, in which S. aureus skin and soft ti

150 okinesis 8 (DOCK8) deficiency is typified by recurrent infections, increased serum IgE levels, eosino

151 We report a new syndrome with recurrent infections, inflammation, and hyperzincaemia a

152 Recurrent infection is infrequently transmitted (2%) and

153 The hyper-IgE syndrome with recurrent infections is a rare immunodeficiency characte

154 le immunodeficiency (CVID), characterized by recurrent infections, is the most prevalent symptomatic

155 ic obstructive pulmonary disease patients to recurrent infections, leading to exacerbations and contr

156 imary ciliary dyskinesia, with upper-airways recurrent infections, left-right asymmetry perturbations

157 in M (IgM) syndrome (HIGM), characterized by recurrent infections, low serum IgG and IgA, normal or e

158 ating differential effects of antibiotics on recurrent infection may be warranted.

159 The recurrent infection may have induced accumulation of AAT

160 of viral infections in infancy, and in turn, recurrent infections may influence the development of im

161 Patients show hypopigmentation, recurrent infections, mild coagulation defects and varyi

162 After treatment with AAQ + PQ, recurrent infection occurred in 0 of 167 patients within

163 Recurrent infections occurred in 3 of 7 patients who sur

164 Recurrent infection of the graft is universal in HCV pat

165 ukocytes, consistent with the neuropathy and recurrent infection of the human patients possessing the

166 Thus, recurrent infection of these developing B cell populatio

167 mophilus influenzae (NTHI) frequently causes recurrent infections of the respiratory tract in humans.

168 ons in the upper respiratory tract and skin, recurrent infections of the respiratory tract, and skin

169 isorder of ciliary beating, characterized by recurrent infections of the upper and lower airways, as

170 Affected persons suffer from recurrent infections of upper and lower airways because

171 axis to sterilize the urine and thus prevent recurrent infection, or abolishing reflux via surgical i

172 also presented that in 45% of patients with recurrent infections, oral and vulvovaginal isolates wer

173 Chronically critically ill patients have recurrent infections, organ dysfunction, and at least ha

174 cent serum antibody levels with incidence of recurrent infection over 12 months follow-up in 235 chil

175 parasitemia did not differ between acute and recurrent infections (P = .48 in Thailand, P = .08 in In

176 eding diathesis, neutropenia, and history of recurrent infections prompted consideration of the diagn

177 A 28-year-old man presented with recurrent infections, reduced class-switched memory B ce

178 ection was also associated with a history of recurrent infection (relative risk, 5.58 in the universi

179 592 was underrepresented in individuals with recurrent infection (RO, 0.59; P=.046).

180 The NEIL3 mutation was associated with fatal recurrent infections, severe autoimmunity, hypogammaglob

181 luded developmental delay, seizures, ataxia, recurrent infections, severe language deficit, and an un

182 Recurrent infection that can progress to life-threatenin

183 In each of the 18 patients with recurrent infections, the same strain was responsible fo

184 Recurrent infections, thermolability, and other complica

185 d wound healing, which increases the risk of recurrent infections, tissue necrosis, and limb amputati

186 cipants were examined for adverse events and recurrent infection twice per week.

187 A recurrent infection was defined as a MSSA blood culture

188 icans isolates from each of 18 patients with recurrent infections was assessed by sequential DNA fing

189 After one lung transplant patient with recurrent infections was noted to be severely hypogammag

190 To determine whether PD-1 contributes to recurrent infection, we first established a model of rei

191 Factors associated with recurrent infection were history of sternotomy (p = 0.00

192 lates from 74 trainees, 6 (8.1%) of whom had recurrent infection, were subjected to WGS.

193 reus is responsible for numerous chronic and recurrent infections, which are frequently associated wi

194 nd lacks immunoglobulins and B cells and has recurrent infections, while the elder, affected brother

195 nce of a chronic state, and development of a recurrent infection with autoimmunity.

196 Lamivudine appears to limit recurrent infection with hepatitis B virus in a signific

197 Recurrent infection with hepatitis C virus (HCV) is almo

198 c fibrosis (CF), a disease in which there is recurrent infection with known pathogens.

199 as how it can lead to a chronic infection or recurrent infection with relapses and remissions.

200 sphate oxidase activity and characterized by recurrent infections with a limited spectrum of bacteria

201 able immune deficiency, a syndrome marked by recurrent infections with encapsulated microorganisms, i

202 Recurrent infections with high-risk human papillomavirus

203 Moreover, 78% of the pigs had recurrent infections with IAVs closely related to each o

204 swelling often associated with fibrosis and recurrent infections with no available cures to date.

205 odeficiency (CID) is characterized by severe recurrent infections with normal numbers of T and B lymp

206 Recurrent infections with respiratory syncytial virus (R

207 ous disease (CGD) is characterized by severe recurrent infections with Staphylococcus aureus, certain

208 patients have decreased quality of life and recurrent infections with treatments limited to palliati

209 Recurrent infections with USA300 MRSA are common, yet in